Ovarian Reserve in Diabetes Mellitus

Status Completed

Clinical Trial Summary

Type 1 diabetes mellitus is a common autoimmune disease. It affects women of all ages including reproductive years. Hyperglycemic condition in diabetes can cause organ damage. This study aims to measure serum hormones including FSH, LH, E2, AMH, ovarian volume and antral follicle count (indicators of ovarian reserve) in women with and without type 1 diabetes mellitus.

Clinical Trial Description

Type 1 diabetes mellitus is a common autoimmune disease. It affects women of all ages including reproductive years. It is showed that hyperglycemic state in diabetes results in organ damage like kidneys and eyes. Ovarian reserve is important for the reproductive period. The measurements of serum hormones including follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and anti-mullerian hormone (AMH) will give us an idea about the ovarian reserve. The investigators aim is to measure ovarian reserve parameters in patients diagnosed with type 1 diabetes mellitus and to compare them to healthy controls. Serum FSH, LH, E2 and AMH will be measured on the 3rd day of the cycle. Antral follicle count and ovarian volume measurement will be done with ultrasonography. Ovarian reserve markers will be compared between the groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03859856
Study type	Observational
Source	Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status	Completed
Phase
Start date	November 25, 2018
Completion date	August 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03623113` - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes	N/A
Withdrawn	`NCT03396484` - Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes	Phase 2
Completed	`NCT03117998` - Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus	Phase 2
Recruiting	`NCT03369821` - EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Completed	`NCT03202732` - DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes	N/A
Completed	`NCT03704818` - Dapagliflozin Effects on Hypoglycemia	Phase 1
Recruiting	`NCT03864991` - Lifestyle Changes and Glycemic Control in T1D	N/A
Completed	`NCT03725657` - Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 Patients
Completed	`NCT02985866` - The International Diabetes Closed Loop (iDCL) Trial: Protocol 1	N/A
Completed	`NCT03003806` - Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study	N/A
Withdrawn	`NCT04147637` - FreeStyle Libre Plus Bluetooth Transmitter Adjunct: Can This Improve Glucose Accuracy and Reduce Burden of Hypoglycaemia	N/A
Completed	`NCT03970889` - Real-time Reminders To Decrease Late or Missed Meal Boluses	N/A
Recruiting	`NCT04589325` - Ixekizumab Diabetes Intervention Trial (I-DIT)	Phase 2
Completed	`NCT03367390` - A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)	Phase 1
Completed	`NCT03738852` - Mechanisms for Restoration of Hypoglycemia Awareness	Early Phase 1
Completed	`NCT03406585` - Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes	Phase 1/Phase 2
Withdrawn	`NCT04102202` - BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus	Phase 1/Phase 2
Terminated	`NCT03353792` - Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients	N/A
Recruiting	`NCT03811470` - China Diabetes Registry by Metabolic Management Center
Completed	`NCT04725799` - Additional Signals for Exercise, Stress and Sleep and Prediction of Glucose Levels for AP Systems